Single-needle return for long-lasting dialysis access
Part of Genetic & congenital, Heart & circulation clinical trials.
This study compares a new single-needle return technique for your dialysis access (AVF) to the usual two-needle method. It aims to see if using just one needle on your fistula and getting the blood back through a leg vein can help your fistula last longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have end-stage kidney disease and receive hemodialysis three times per week.
- You have been using your arteriovenous fistula (AVF) for dialysis for at least the past 3 months.
- You have good veins in at least one leg that can be used for a new return needle.
- You are willing to either try a new single-needle return method or continue your usual two-needle method.
- You do not have any active infections, bleeding problems, or severe health issues that would make the new method unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device that lets you use just one needle for dialysis instead of two. It might make treatments more comfortable and simpler.
This study tests a new device that may make it easier and more reliable to place needles into your dialysis access (the fistula or graft in your arm). It could help improve your dialysis sessions and comfort.
This trial tests a new device called the Velocity pAVF System that creates a connection between a vein and artery in your arm for hemodialysis. If you need dialysis now or within the next 6 months, this could be a new option for you.
This trial tests a small implant device that can make dialysis fistulas easier to access with needles when normal needle access is too difficult or risky. It may help reduce painful failed attempts and needle-related complications for people with certain types of fistulas.
This study monitors how well the BD WavelinQ endoAVF device works after routine clinical use. It may help people who need a dialysis access fistula by sharing real-world safety and performance data.
This trial tests a special wrap placed around a new arm access point for dialysis (called an AV fistula) to see if it helps the access stay healthy and work better. It is for people who need a new AV fistula for kidney dialysis.
Hear when a new Arteriovenous Fistula trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.